Cases of people suffering from Alzheimer's disease have reached epidemic proportions and it is now considered to be the number one public health crisis of the 21st century.
Experts expressed concerns over how the costs of care for Alzheimer's were draining the financial resources of both Medicare and Medicaid, particularly the costs to cover Alzheimer's claims, which were nearly three times higher than the average claims. The cost to Medicare is predicted to climb to 55 percent reaching $50 billion in less than 10 years. The cost to Medicaid doesn't look much better, as it is estimated to rise by 80 percent to $33 billion.
An analysis of 30,000 Medicare claims showed an increase in Alzheimer's disease especially among the African American population where there was a significant jump of 460 percent.
The Rise of Alzheimer's Cases
Baby boomers, who are considered at high risk of developing Alzheimer's, are expected to reach 1 million a year
The number of people with Alzheimer's is predicted to go from today's estimate of 4.5 million to nearly 16 million by the year 2050
Current national costs for providing care to Alzheimer's patients: $100 billion
Study on Costs to Medicare for Alzheimer's Patients
Costs were analyzed over a 15-year period after a person was diagnosed as having Alzheimer's disease
1,600 participants took part in the study
Components of care that were evaluated included years of institutionalized care, hours of paid and informal care and discounted costs of paid community, institutional and medical care
Results of the Study
Due to having a longer life expectancy rates, the average cost of care for a woman with Alzheimer's was around $16,327 per year compared to the cost for a man with Alzheimer's, which was an estimated $9,710 per year
Cost for care in the final stages of the disease were a great deal higher than the costs for the initial stages of the disease
Because of the catastrophic costs and the number of people predicted to develop Alzheimer's, researchers expressed the need for more funding for research with hopes that it will provide them with knowledge on less expensive treatments for Alzheimer's.
As a way of reaching this goal The Alzheimer's Association came up with the following recommendations:
A request for $1 billion in annual federal funding to be used for Alzheimer's research
Guiding Americans to think about Alzheimer's differently and focus on prevention techniques such as lifestyle and improving brain health
Incorporating a chronic health care benefit into the Medicare program to cover the exorbitant costs of care associated to dementia and other related conditions
Improving the quality of care and support services available to people with Alzheimer's
EurekAlert July 19, 2004
The total number of people with Alzheimer's will almost quadruple from an estimated 4.5 million today to as many as 16 million by 2050.
The national direct and indirect costs to cover Alzheimer's care are an astounding $100 billion.
With these kinds of statistics it's critical to take action now. Rather than waiting and depending on Medicare to come up with a benefit to cover these catastrophic costs, it is imperative to take control of your health today to avoid becoming one of these statistics.
Alzheimer's is such a difficult disease to treat and until there is a confirmed cure for it, your best bet is to take preventive measures against it now! These steps to reduce your risk of Alzheimer's are inexpensive, natural and can be easily implemented by anyone:
Related Articles:
Mercury Contributes To Alzheimer's Disease! Alzheimer's Vaccine Causes Life-Threatening Side Effects Low Folate Levels Linked To Alzheimer's Disease You Don't Have to Get Alzheimer's Estrogen No Help in Alzheimerís Study Finds Hormone Is Not An Effective Treatment Drugs Fail to Slow Alzheimer's
Mercury Contributes To Alzheimer's Disease!
Alzheimer's Vaccine Causes Life-Threatening Side Effects
Low Folate Levels Linked To Alzheimer's Disease
You Don't Have to Get Alzheimer's
Estrogen No Help in Alzheimerís Study Finds Hormone Is Not An Effective Treatment
Drugs Fail to Slow Alzheimer's